Evaluation the efficacy of Achillea wilhelmsii capsule in irritable bowel syndrome patients.
- Conditions
- K58.9 , K5Irritable bowel syndrom.Irritable bowel syndrome with diarrhea, Irritable bowel syndrome without diarrhoea
- Registration Number
- IRCT2016110120071N3
- Lead Sponsor
- Vice – Chancellery of Research, Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion criteria : age>18 ; ability to swallow the capsule ; patients who sign the testimonials and cooperate during the study ; patients who are not cured with Achillea wilhelmsii during a last month ; Patients who their diseases are approved by complete medical evaluation.
Exclusion criteria : pregnant patients and nursing mothers ; patients with any active stomach-interic disease ; patients who have to use other drugs that interference with this medication (such as laxative? antidepressants? opioid and narcotic analgesics ) ; patients who are disposed to a serious health danger, such as severe cardiac, liver or renal diseases ; If significant side effects occur, the patient will be excluded from the study ; patients with severe allergy to this plant (dermatitis contact) will be excluded.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diarrhea. Timepoint: Before using the drug-2 weeks after using the drug-30 days after using the drugs. Method of measurement: Based on IBS-QOL and IBS-SEVERITY questionary.;Constipation. Timepoint: Before using the drug-2 weeks after using the drug-30 days after using the drugs. Method of measurement: Based on IBS-QOL and IBS-SEVERITY questionary.;Bloat. Timepoint: Before using the drug-2 weeks after using the drug-30 days after using the drugs. Method of measurement: Based on IBS-QOL and IBS-SEVERITY questionary.;Abdominal pain. Timepoint: Before using the drug-2 weeks after using the drug-30 days after using the drugs. Method of measurement: Based on IBS-QOL and IBS-SEVERITY questionary.
- Secondary Outcome Measures
Name Time Method Photosensivity. Timepoint: Before start use drug-two weeks after use drug-four weeks after use drug. Method of measurement: Based on side effect questionary.;Digestive problems. Timepoint: Before start use drug-two weeks after use drug-four weeks after use drug. Method of measurement: Based on side effect questionary.